lobbying_filings_raw: f356a8c3-e2e5-4f7e-b5eb-93ddc31fa066
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| f356a8c3-e2e5-4f7e-b5eb-93ddc31fa066 | Q1 | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 184073 | INDEPENDENT PHARMACY COOPERATIVE | 2024 | first_quarter | 2024-04-12T14:20:59-04:00 | 130000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/f356a8c3-e2e5-4f7e-b5eb-93ddc31fa066/", "filing_uuid": "f356a8c3-e2e5-4f7e-b5eb-93ddc31fa066", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2024, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f356a8c3-e2e5-4f7e-b5eb-93ddc31fa066/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "130000.00", "expenses_method": "A", "expenses_method_display": "A", "posted_by_name": "Mark Kinney", "dt_posted": "2024-04-12T14:20:59-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1550 Columbus Street", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Sun Prairie", "registrant_state": "WI", "registrant_zip": "53590", "registrant": {"id": 313098, "url": "https://lda.senate.gov/api/v1/registrants/313098/", "house_registrant_id": 39121, "name": "INDEPENDENT PHARMACY COOPERATIVE", "description": null, "address_1": "1550 Columbus Street", "address_2": null, "address_3": null, "address_4": null, "city": "Sun Prairie", "state": "WI", "state_display": "Wisconsin", "zip": "53590", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MR. MARK KINNEY", "contact_telephone": "+1 608-628-7311", "dt_updated": "2026-01-23T13:08:18.689548-05:00"}, "client": {"id": 184073, "url": "https://lda.senate.gov/api/v1/clients/184073/", "client_id": 12, "name": "INDEPENDENT PHARMACY COOPERATIVE", "general_description": "National GPO and drug distribution services for independent pharmacies.", "client_government_entity": false, "client_self_select": true, "state": "WI", "state_display": "Wisconsin", "country": "US", "country_display": "United States of America", "ppb_state": "WI", "ppb_state_display": "Wisconsin", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-07-16"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "IPC supports Drug Transparency in Medicaid Act (H.R. 1613) ICP supports Promoting Access to Treatments and Increasing Extremely Needed Transparent (PATIENT) Act (HR 3561) IPC supports Drug Transparency in Medicaid Act (S. 1038) IPC supports The Modernizing and Ensuring PBM Accountability Act (S 2973) IPC supports Pharmacy and Medically Underserved Areas Enhancement Act (S 1491) IPC supports Protecting Patients Access to Pharmacy Act (S. 2052) IPC supports The Health Care Price Transparency Act (H.R. 4822) IPC supports Lower Cost, More Transparency Act (LCMT) (H.R. 5378) IPC supports Protecting Patients Against PBM Abuses Act (H.R. 2880) IPC Transparency and Fairness for Pharmacies Act (H.R. 5393) IPC supports Senate Bi-Partisan Working Group for 340B Reform - RFI response. IPC Supports FDA - Development of Small Dispensers Assessment Under the Drug Supply Chain Security Act; Request for Comments (FDA-2023-N-3103) IPC supports the Inflation Reduction Act of 2022 and CMS implementation. IPC opposes S. 1339 Pharmacy Benefits Reform Act - because it may preempt state PBM laws relating to ERISA. IPC supports S. 1491 Pharmacy and Medically Underserved Areas Enhancement Act IPC supports S. 127 Pharmacy Benefit Manager Transparency Act IPC supports (H.R. 1770/S. 2477) The Equitable Community Access to Pharmacists Services Act CMS Implementation of PY 2024 Medicare Part D drug rule CMS Implementation of drug provisions of the IRA 2022.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 21818, "prefix": "mr", "prefix_display": "MR.", "first_name": "MARK", "nickname": null, "middle_name": "EUGENE", "last_name": "KINNEY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 65102, "prefix": null, "prefix_display": null, "first_name": "JOHN", "nickname": null, "middle_name": "A.", "last_name": "COVELLO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 64, "name": "Federal Trade Commission (FTC)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |